240 related articles for article (PubMed ID: 22517588)
1. Musashi 2 in hematopoiesis.
de Andrés-Aguayo L; Varas F; Graf T
Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
[TBL] [Abstract][Full Text] [Related]
2. Roles for MSI2 and PROX1 in hematopoietic stem cell activity.
Hope KJ; Sauvageau G
Curr Opin Hematol; 2011 Jul; 18(4):203-7. PubMed ID: 21577104
[TBL] [Abstract][Full Text] [Related]
3. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
Kharas MG; Lengner CJ; Al-Shahrour F; Bullinger L; Ball B; Zaidi S; Morgan K; Tam W; Paktinat M; Okabe R; Gozo M; Einhorn W; Lane SW; Scholl C; Fröhling S; Fleming M; Ebert BL; Gilliland DG; Jaenisch R; Daley GQ
Nat Med; 2010 Aug; 16(8):903-8. PubMed ID: 20616797
[TBL] [Abstract][Full Text] [Related]
4. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
[TBL] [Abstract][Full Text] [Related]
5. HOX and non-HOX homeobox genes in leukemic hematopoiesis.
Owens BM; Hawley RG
Stem Cells; 2002; 20(5):364-79. PubMed ID: 12351808
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathogenesis of acute myeloid leukemia.
Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
[TBL] [Abstract][Full Text] [Related]
7. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
Kaeda J; Ringel F; Oberender C; Mills K; Quintarelli C; Pane F; Koschmieder S; Slany R; Schwarzer R; Saglio G; Hemmati P; van Lessen A; Amini L; Gresse M; Vagge E; Burmeister T; Serra A; Carson A; Schwarz M; Westermann J; Jundt F; Dörken B; le Coutre P
Leuk Lymphoma; 2015 Jul; 56(7):2105-13. PubMed ID: 25363400
[TBL] [Abstract][Full Text] [Related]
9. Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.
Ganapati U; Tan HT; Lynch M; Dolezal M; de Vos S; Gasson JC
Stem Cells; 2007 Aug; 25(8):1872-80. PubMed ID: 17464091
[TBL] [Abstract][Full Text] [Related]
10. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of IRS2 in myelodysplastic syndrome: a possible role in impaired hematopoietic cell differentiation.
Machado-Neto JA; Favaro P; Lazarini M; da Silva Santos Duarte A; Archangelo LF; Lorand-Metze I; Costa FF; Saad ST; Traina F
Leuk Res; 2012 Jul; 36(7):931-5. PubMed ID: 22465474
[TBL] [Abstract][Full Text] [Related]
12. Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis.
Le PM; Andreeff M; Battula VL
Haematologica; 2018 Dec; 103(12):1945-1955. PubMed ID: 30337364
[TBL] [Abstract][Full Text] [Related]
13. PLAG1 and USF2 Co-regulate Expression of Musashi-2 in Human Hematopoietic Stem and Progenitor Cells.
Belew MS; Bhatia S; Keyvani Chahi A; Rentas S; Draper JS; Hope KJ
Stem Cell Reports; 2018 Apr; 10(4):1384-1397. PubMed ID: 29641991
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
Testa U; Pelosi E
Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
[TBL] [Abstract][Full Text] [Related]
15. [Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].
Baskaran D; Spirin PV; Prasolov VS
Mol Biol (Mosk); 2010; 44(3):418-30. PubMed ID: 20608165
[TBL] [Abstract][Full Text] [Related]
16. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
17. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
18. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
19. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNAs in normal and malignant hematopoiesis.
Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]